| Preferred name | dextro,laevo-homatropine hydrobromide |
| Trivial Name | Homatropine hydrobromide |
| Short Description | homatropine DL- hydrobromide |
| Formula | C16 H22 Br N O3 |
| CAS Number | 51-56-9 |
| ECHA Number | 200-105-3 |
| FDA UNII | BEW7469QZ0 |
| MDL | MFCD00012676 |
| Bio Activity Summary | External link |
| NMR Predictor | External link |
| Synonyms |
|
| Google Scholar | Start search |
| Google Books | Start search |
| Google Patents | Start search |
| Perfumer & Flavorists | Start search |
| EU Patents | Start search |
| PubMeb | Start search |
| NCBI | Start search |
| (8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenylacetate;hydrobromide | |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 5821 |
| Pubchem (sid): | 134972439 |
| (IUPAC): | Atomic Weights of the Elements 2011 (pdf) |
| Videos: | The Periodic Table of Videos |
| tgsc: | Atomic Weights use for this web site |
| (IUPAC): | Periodic Table of the Elements |
| HMDB (The Human Metabolome Database): | Search |
| Export Tariff Code: | 2933.99.9700 |
| ChemSpider: | View |
| BOC Sciences | ExtraSynthese |
| Glentham Life Sciences | Santa Cruz Biotechnology |
| Sigma-Aldrich | TCI AMERICA |
| Material listed in food chemical codex | No |
| Molecular weight | 356.25994873047 |
| Flash Point TCC Value | N/a |
| Solubility | |
| water, 1.49E+05 mg/L @ 25 °C (exp) | Yes |
| water, 2.042e+004 mg/L @ 25 °C (est) | Yes |
| Preferred SDS: View | |
| Hazards identification | |
| Classification of the substance or mixture | |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) | |
| None found. | |
| GHS Label elements, including precautionary statements | |
| Pictogram | |
| Hazard statement(s) | |
| None found. | |
| Precautionary statement(s) | |
| None found. | |
| Oral/Parenteral Toxicity: | |
| intravenous-mouse LD50 107 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 96, Pg. 1, 1949. intraperitoneal-rat LD50 154 mg/kg Drugs in Japan Vol. 6, Pg. 789, 1982. | |
| Dermal Toxicity: | |
| Not determined | |
| Inhalation Toxicity: | |
| Not determined | |
| Category: | |||
| pharmaceuticals / chemical synthisis | |||
| Recommendation for dextro,laevo-homatropine hydrobromide usage levels up to: | |||
| not for fragrance use. | |||
| Recommendation for dextro,laevo-homatropine hydrobromide flavor usage levels up to: | |||
| not for flavor use. | |||
| EPI System: View |
| Daily Med:search |
| AIDS Citations:Search |
| Cancer Citations:Search |
| Toxicology Citations:Search |
| EPA Substance Registry Services (TSCA):51-56-9 |
| EPA ACToR:Toxicology Data |
| EPA Substance Registry Services (SRS):Registry |
| Laboratory Chemical Safety Summary :5821 |
| National Institute of Allergy and Infectious Diseases:Data |
| WGK Germany:3 |
| (8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenylacetate;hydrobromide |
| Chemidplus:0000051569 |
| RTECS:YM5602000 for cas# 51-56-9 |